Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P346: The application of indocyanine green during robotic surgery for IBDECCO '18 Vienna
Year: 2018
Authors:

M.V. Marino1*, A.L. Komorowski2

1Azienda Ospedaliera Villa Sofia-Cervello, Emergency and General Surgery, Palermo, Italy, 2Maria Skłodowska-Curie Memorial Institute of Oncology Cancer Centre, Krakow, Poland

P347: Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAIDECCO '18 Vienna
Year: 2018
Authors:

B. Caron1, L. Peyrin-Biroulet2, M. Nachury3, Y. Bouhnik4, P. Seksik5, G. Bouguen6, L. Caillo7, D. Laharie8, F. Carbonnel9, R. Altwegg10, C. Reenaers11, M. Serrero12, A. Boureille13, S. Nancey14, J. Filippi15, V. Abitbol1*6, G. Savoye17, L. Vuitton18, S. Viennot19, M. Fumery20, M. Reymond21, J.P. Bronowicki22, J.-M. Reimund23, A. Amiot24

1CHU Strasbourg, Department of Gastroenterology and Hepatology, Strasbourg, France, 2CHU Nancy, Department of Gastroenterology and Hepatology, Vandoeuvre-Lès-Nancy, France, 3CHRU Lille, Department of Gastroenterology, Lille, France, 4CHU Beaujon, Department of Gastroenterology, Clichy, France, 5CHU Saint-Antoine, Department of Gastroenterology, Paris, France, 6CHU Pontchaillou, Department of Gastroenterology, Rennes, France, 7CHU Nimes, Department of Gastroenterology and Hepatology, Nimes, France, 8CHU Bordeaux, Department of Gastroenterology, Bordeaux, France, 9CHU Bicêtre, Department of Gastroenterology, Le Kremlin-Bicêtre, France, 10CHU Montpellier Saint Eloi Hospital, Department of Gastroenterology, Montpellier, France, 11CHU Liège, Sart Tilman, Department of Gastroenterology, Liège, Belgium, 12CHU Marseille, Department of Gastroenterology and Hepatology, Marseille, France, 13CHU Nantes, Department of Gastroenterology and Hepatology, Nantes, France, 14Hospital Edouard Herriot, Department of Gastroenterology and Hepatology, Lyon, France, 15Archet 2 Hospital, Department of Gastroenterology, Nice, France, 16Cochin Hospital, Department of Gastroenterology, Paris, France, 17Rouen Hospital, Department of Gastroenterology and Hepatology, Rouen, France, 18CHU Besancon, Department of Gastroenterology and Hepatology, Besançon, France, 19Hospital Cote de Nacre, Department of Gastroenterology, Caen Cede, France, 20Amiens University Hospital, Department of Gastroenterology, Amiens, France, 21CHU Clermont-Ferrand, Department of Gastroenterology and Hepatology, Clermont Ferrand, France, 22CHU Nancy, Department of Gastroenterology and Hepatology, Nancy, France, 23CHU Strasbourg, Strasbourg, France, 24Henri Mondor Hospital, Gastroenterology, Creteil, France

P348: 3D reconstructions in complex fistulising perianal Crohn’s disease to aid decision-makingECCO '18 Vienna
Year: 2018
Authors:

K. Sahnan1*, S.O. Adegbola1, P.J. Tozer1, D. Burling2, A. Gupta2, J. Warusavitarne1, O.D. Faiz1, R.K. Phillips1, A.L. Hart3, P.F. Lung2

1St Mark's Hospital, Colorectal Surgery, London, UK, 2St Mark's Hospital, Gastrointestinal Imaging, London, UK, 3St Mark's Hospital, IBD/Physiology, London, UK

P349: Deep enteroscopy with a through-the-scope ballon catheter system in paediatric patients with IBDECCO '18 Vienna
Year: 2018
Authors:

E. Broide1,2*, T. Shalem1,3, H. Shirin1,2

1Assaf Harofeh Medical Center, The Kamila Gonczarowski institute of Gastroenterology Assaf Harofeh Medical Center, Zerifin, Israel, 2Tel Aviv university Sackler school of medicin, internal medicine, Tel aviv, Israel, 3Tel Aviv university Sackler school of medicin, internal medicine, Tel Aviv, Israel

P350: Conventional biomarkers in newly diagnosed Crohn’s disease patients may predict early disease progressionECCO '18 Vienna
Year: 2018
Authors:

H. Yanai1,2*, I. Goren1,2, L. Godny1,2, S. Ben-Shachar2,3, N. Maharshak2,4, Y. Ron2,4, K. Yadgar1, K. Zonenesain1, T. Ziv-Baran5, I. Dotan1,2

1Rabin Medical Center, Beilinson Hospital, Department of Gastroenterology, Petah Tikva, Israel, 2Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel, 3Tel Aviv Sourasky Medical Center, Genetic Institute, Tel Aviv, Israel, 4Tel Aviv Sourasky Medical Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel, 5Tel Aviv University, Israel, Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv, Israel

P351: Bowel ultrasound is accurate in assessing disease activity in ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

M. Allocca1*, G. Fiorino1, F. Furfaro1, S. Radice1, D. Gilardi1, L. Peyrin-Biroulet2, S. Danese1

1Humanitas Clinical and Research Institute, Rozzano, Italy, 2University of Nancy, Nancy, France

P352: Is diagnostic delay associated with the risk of colectomy in patients with ulcerative colitis? Results of a study of the Austrian IBD study groupECCO '18 Vienna
Year: 2018
Authors:

G. Novacek1*, H.P. Gröchenig2, T. Haas3, H. Wenzl4, P. Steiner5, R. Koch6, T. Feichtenschlager7, G. Eckhardt8, A. Mayer9, A. Kirchgatterer10, O. Ludwiczek11, R. Platzer12, P. Papay13, J. Gartner14, H. Fuchssteiner15, W. Miehsler16, P. Peters17, G. Reicht18, H. Vogelsang1, C. Dejaco1, T. Waldhör19

1Medical University of Vienna, Department of Internal Medicine III, Vienna, Austria, 2Hospital Barmherzige Brüder St. Veit an der Glan, Department of Internal Medicine, St. Veit an der Glan, Austria, 3Darmpraxis Salzburg, Salzburg, Austria, 4Medical University of Graz, Department of Gastroenterology and Hepatology, Graz, Austria, 5Hospital Wels-Grieskirchen, Department of Internal Medicine I, Wels, Austria, 6Medical University of Innsbruck, Department of Internal Medicine I, Innsbruck, Austria, 7Hospital Rudolfstiftung, Department of Internal Medicine IV, Vienna, Austria, 8Hospital Oberpullendorf, Department of Internal Medicine, Oberpullendorf, Austria, 9Universitätsklinikum St. Pölten, Department of Internal Medicine II, St. Pölten, Austria, 10Hospital Wels-Grieskirchen, Department of Internal Medicine V, Grieskirchen, Austria, 11Hospital Hall in Tirol, Department of Internal Medicine, Hall in Tirol, Austria, 12Hospital Wiener Neustadt, Department of Internal Medicine I, Wiener Neustadt, Austria, 13Hartmannspital, Department of Internal Medicine, Vienna, Austria, 14Hanusch Hospital, Department of Internal Medicine, Vienna, Austria, 15Hospital Elisabethinen Linz, Department of Internal Medicine IV, Linz, Austria, 16Hospital Barmherzige Brüder Salzburg, Department of Internal Medicine, Salzburg, Austria, 17Hospital Feldkirch, Department of Internal Medicine, Feldkirch, Austria, 18Hospital Barmherzige Brüder Graz, Department of Internal Medicine, Graz, Austria, 19Medical University of Vienna, Department of Epidemiology, Vienna, Austria

P353: Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea: An updateECCO '18 Vienna
Year: 2018
Authors:

S.-H. Lee1*, K. Chang1, M.-J. Kim2, E.M. Song1, S.W. Hwang1,3, D.-H. Yang1, J.-S. Byeon1, S.-J. Myung1, S.-K. Yang1,3, B.D. Ye1,3

1University of Ulsan College of Medicine, Asan Medical Center, Department of Gastroenterology, Seoul, South Korea, 2University of Ulsan College of Medicine, Asan Medical Center, Department of Clinical Epidemiology and Biostatistics, Seoul, South Korea, 3University of Ulsan College of Medicine, Asan Medical Center, Inflammatory Bowel Disease Center, Seoul, South Korea

P354: Refinement and confirmation of psychometric properties of the Inflammatory Bowel Disease Distress Scale (IBD-DS): A new tool to measure disease-specific distressECCO '18 Vienna
Year: 2018
Authors:

L. Dibley1,2*, W. Czuber-Dochan3, S. Woodward3, T. Wade3, P. Bassett4, J. Sturt3, C. Norton3, The IBD-DS Patient and Public Involvement Team3

1University of Greenwich, Faculty of Education and Health, London, UK, 2Bart's Health NHS Trust, Academic Research Centre, London, UK, 3King's College London, Florence Nightingale School of Nursing and Midwifery, London, UK, 4Stats Consultancy, Amersham, UK

P355: Prevalence, clinical characteristics and outcomes of CMV colitis in a cohort of 95 patients with ulcerative colitis: A 7-year retrospective analysisECCO '18 Vienna
Year: 2018
Authors:

J. Carvão1*, J. Alves2, V. Magno Pereira1, C. Sousa Andrade1, H. Morna1, G. Andrade2, L. Jasmins1

1Hospital Central do Funchal, Gastroenterology, Funchal, Portugal, 2Hospital Central do Funchal, Clinical Pathology, Funchal, Portugal

P356: The role of endoscopic activity in the coagulation profile of clinical remission Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

A. Andrade*, M. Azevedo, A. Carlos, C. Hashimoto, A. Sipahi, A. Damião, E. D´Amico, A. Leite

Faculdade de Medicina da USP, Gastroenterology, São Paulo, Brazil

P357: Healthcare and medication utilisation in Singapore adult inflammatory bowel disease patients receiving immunomodulators and biologicsECCO '18 Vienna
Year: 2018
Authors:

R.E.L. Gan1,2,3, C.K.Y. Ng1, W.C. Ong1, W.P.W. Chan2,3, B.J. Schwender2,3, S.C. Kong2,3, H.H. Shim2,3, K.L. Ling2,3, S.W. Chuah2,3, T.G. Lim1,3*

1Singapore General Hospital, Pharmacy, Singapore, Singapore, 2Singapore General Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore, 3Duke-NUS Medical School, Singapore, Singapore

P358: Factors associated with disability in inflammatory bowel disease (IBD): A cross-sectional study in outpatientsECCO '18 Vienna
Year: 2018
Authors:

J.M. Costa1*, D. Matos2, R. Costa1, B. Arroja1, R. Gonçalves1, J.B. Soares1

1Hospital de Braga, Gastroenterology, Braga, Portugal, 2School of Health Sciences, University of Minho, Braga, Portugal

P359: A novel phase 1 trial design to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of TOP1288, a narrow spectrum kinase inhibitor, delivered topically to the colon via oral administrationECCO '18 Vienna
Year: 2018
Authors:

A. Rowley1*, M. Taylor1, A. Duggal1, M. Foster1, S. Sirohi1, Y. Solanke1, C. Walshe1, M. Fyfe1, S. Webber1, S. Travis2

1TopiVert Pharma Ltd., London, UK, 2Oxford University Hospitals Trust, Translational Gastroenterology Unit, Oxford, UK

P360: TrueColours ulcerative colitis (TCUC): Will patients with UC complete digital questionnaires in real-time?ECCO '18 Vienna
Year: 2018
Authors:

A. Walsh1*, M. Peters2, C. Hinds3, A. Kormilitzin4, V. Sexton5, P. Seeva1, O. Brain1, S. Keshav1, H. Uhlig1, A. Simmons6, J. Geddes5, G. Goodwin5, G. Collins7, S. Travis1

1John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, UK, 2University of Oxford, Nuffield Department of Population Health, Oxford, UK, 3Big Data Institute, Oxford, UK, 4Mathematical Institute, Oxford, UK, 5University of Oxford, Psychiatry Department, Oxford, UK, 6Weatherall Institute of Molecular Medicine, Oxford, UK, 7University of Oxford, Centre for Statistics in Medicine, Oxford, UK

P361: Patterns of use and durability of initial and sequential biological agents in a large Paediatric inflammatory bowel disease observational cohortECCO '18 Vienna
Year: 2018
Authors:

J. Kaplan1,2*, C. Liu3, E. King3, J. Bass4, A. Patel5, G. Tomer6, J. Tung7, J. Pratt3, S. Chen3, T. Lissoos8, R. Colletti9, ImproveCareNow Network

1MassGeneral Hospital for Children, Pediatric Gastroenterology, Boston, USA, 2Harvard Medical School, Boston, USA, 3Cincinnati Children's Hospital, Cincinnati, USA, 4Children’s Mercy Hospital, Kansas City, USA, 5University of Texas-Southwestern/Children's Medical Center, Dallas, USA, 6The Children’s Hospital at Montefiore, Bronx, USA, 7Mayo Clinic-Children’s Center, Rochester, USA, 8Takeda Pharmaceuticals USA, Deerfield, USA, 9University of Vermont College of Medicine, Burlington, USA

P362: Six-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patientsECCO '18 Vienna
Year: 2018
Authors:

C. Cassieri1*, R. Pica1, E.V. Avallone1, G. Brandimarte2, M. Zippi1, P. Crispino1, D. De Nitto1, P.G. Lecca2, P. Vernia1, P. Paoluzi1, E.S. Corazziari1

1Sapienza University, Department of Internal Medicine and Medical Specialties, Rome, Italy, Rome, Italy, 2Cristo Re, Hospital, Internal Medicine, “Cristo Re” Hospital, Rome, Italy, Rome, Italy

P363: Discontinuation of 5-aminosalicylates after starting biologic therapy in patients with ulcerative colitis is not associated with adverse outcomesECCO '18 Vienna
Year: 2018
Authors:

B. Limketkai1*, R. Ungaro2, T. Jess3, K. Allin3, M. Agrawal4, T. Ullman2, J.-F. Colombel2

1Stanford University School of Medicine, Gastroenterology and Hepatology, Stanford, California, USA, 2Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, New York, USA, 3Frederiksberg Hospital, Clinical Epidemiology, Frederiksberg, Denmark, 4Montefiore Medical Center, Gastroenterology, Bronx, USA

P364: Stopping azathioprine in monotherapy after very prolonged remission in inflammatory bowel disease patients: Novel relapse risk factorsECCO '18 Vienna
Year: 2018
Authors:

M. Iborra1*, J. Herreras2, M. Boscá-Watts3, X. Cortés4, G. Trejo3, B. Beltran1, E. Cerrillo1, M. Minguez3, P. Nos1

1La Fe University and Polytechnic Hospital and CIBER-EHD, Department of Gastroenterology, Valencia, Spain, 2La Fe University and Polytechnic hospital of Valencia, Department of Gastroenterology and Hepatology, Valencia, Spain, 3University Clinic Hospital of Valencia, Department of Gastroenterology and Hepatology, Valencia, Spain, 4Hospital de Sagunto (Sagunto), Department of Gastroenterology, Valencia, Spain

P365: Biological interventions for induction and maintenance of mucosal healing in Crohn’s disease: A Cochrane systematic reviewECCO '18 Vienna
Year: 2018
Authors:

A. Ricciuto1*, P. Church1, M.J. Stewart2, H.H. Shim2, M. Storr3,4, R. Panaccione2, A. Griffiths1, C. Seow2

1Hospital for Sick Children, University of Toronto, Toronto, Canada, 2University of Calgary, Medicine, Calgary, Canada, 3Ludwig-Maximilians-University Munich, Munich, Germany, 4Center of Endoscopy, Starnberg, Germany